NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|148540000|ref|NP_083277|]
View 

very long chain fatty acid elongase 7 [Mus musculus]

Protein Classification

elongation of very long chain fatty acids protein( domain architecture ID 10471715)

elongation of very long chain fatty acids protein catalyzes the first and rate-limiting reaction of the four steps that constitute the long-chain fatty acids elongation cycle

EC:  2.3.1.199
Gene Ontology:  GO:0009922|GO:0042761

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
ELO pfam01151
GNS1/SUR4 family; Members of this family are involved in long chain fatty acid elongation ...
29-269 1.08e-74

GNS1/SUR4 family; Members of this family are involved in long chain fatty acid elongation systems that produce the 26-carbon precursors for ceramide and sphingolipid synthesis. Predicted to be integral membrane proteins, in eukaryotes they are probably located on the endoplasmic reticulum. Yeast ELO3 affects plasma membrane H+-ATPase activity, and may act on a glucose-signaling pathway that controls the expression of several genes that are transcriptionally regulated by glucose such as PMA1.


:

Pssm-ID: 460083  Cd Length: 242  Bit Score: 228.27  E-value: 1.08e-74
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000   29 LLMSSPLPQTIILGLYVYFVtSLGPKLMENRKPFELKKAMITYNFFIVLFSVYMCYEFVMSGWGTGYSFRCDIVDYSQSP 108
Cdd:pfam01151   1 PLLSSPDPVILIIVLYLLFV-FLGPKLMRNRKPFDLRRLLIVYNLFLSLFSLYGFYGMLPALLGWLYGFFWSLCQPSESP 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000  109 RAMRMVH-TCWLYYFSKFIELLDTIFFVLRKKnsQVTFLHVFHHTIMPWTWWFGVKFAAGGLGTFHAFLNTAVHVVMYSY 187
Cdd:pfam01151  80 FAQGLVGfWYYLFYLSKILELLDTVFLVLRKK--QLSFLHVYHHSTMLLYSWLGYKYGTGGVGWFFILLNSFVHVIMYFY 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000  188 YGLCAMGpayQKYL--WWKKHLTSLQLVQFVLVTIHIGQIFFM-----EDCNYQyPVFLYIIMSYGCIFLLLFLHFWYRA 260
Cdd:pfam01151 158 YFLAALG---NKKLprWWKKYITQLQILQFVIGLAHTVYALYQyylgpYGCDGP-RFAARLGLVMYLSYLFLFSNFYIKS 233

                  ....*....
gi 148540000  261 YTKGQRLPK 269
Cdd:pfam01151 234 YLKPKKKKA 242
 
Name Accession Description Interval E-value
ELO pfam01151
GNS1/SUR4 family; Members of this family are involved in long chain fatty acid elongation ...
29-269 1.08e-74

GNS1/SUR4 family; Members of this family are involved in long chain fatty acid elongation systems that produce the 26-carbon precursors for ceramide and sphingolipid synthesis. Predicted to be integral membrane proteins, in eukaryotes they are probably located on the endoplasmic reticulum. Yeast ELO3 affects plasma membrane H+-ATPase activity, and may act on a glucose-signaling pathway that controls the expression of several genes that are transcriptionally regulated by glucose such as PMA1.


Pssm-ID: 460083  Cd Length: 242  Bit Score: 228.27  E-value: 1.08e-74
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000   29 LLMSSPLPQTIILGLYVYFVtSLGPKLMENRKPFELKKAMITYNFFIVLFSVYMCYEFVMSGWGTGYSFRCDIVDYSQSP 108
Cdd:pfam01151   1 PLLSSPDPVILIIVLYLLFV-FLGPKLMRNRKPFDLRRLLIVYNLFLSLFSLYGFYGMLPALLGWLYGFFWSLCQPSESP 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000  109 RAMRMVH-TCWLYYFSKFIELLDTIFFVLRKKnsQVTFLHVFHHTIMPWTWWFGVKFAAGGLGTFHAFLNTAVHVVMYSY 187
Cdd:pfam01151  80 FAQGLVGfWYYLFYLSKILELLDTVFLVLRKK--QLSFLHVYHHSTMLLYSWLGYKYGTGGVGWFFILLNSFVHVIMYFY 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000  188 YGLCAMGpayQKYL--WWKKHLTSLQLVQFVLVTIHIGQIFFM-----EDCNYQyPVFLYIIMSYGCIFLLLFLHFWYRA 260
Cdd:pfam01151 158 YFLAALG---NKKLprWWKKYITQLQILQFVIGLAHTVYALYQyylgpYGCDGP-RFAARLGLVMYLSYLFLFSNFYIKS 233

                  ....*....
gi 148540000  261 YTKGQRLPK 269
Cdd:pfam01151 234 YLKPKKKKA 242
 
Name Accession Description Interval E-value
ELO pfam01151
GNS1/SUR4 family; Members of this family are involved in long chain fatty acid elongation ...
29-269 1.08e-74

GNS1/SUR4 family; Members of this family are involved in long chain fatty acid elongation systems that produce the 26-carbon precursors for ceramide and sphingolipid synthesis. Predicted to be integral membrane proteins, in eukaryotes they are probably located on the endoplasmic reticulum. Yeast ELO3 affects plasma membrane H+-ATPase activity, and may act on a glucose-signaling pathway that controls the expression of several genes that are transcriptionally regulated by glucose such as PMA1.


Pssm-ID: 460083  Cd Length: 242  Bit Score: 228.27  E-value: 1.08e-74
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000   29 LLMSSPLPQTIILGLYVYFVtSLGPKLMENRKPFELKKAMITYNFFIVLFSVYMCYEFVMSGWGTGYSFRCDIVDYSQSP 108
Cdd:pfam01151   1 PLLSSPDPVILIIVLYLLFV-FLGPKLMRNRKPFDLRRLLIVYNLFLSLFSLYGFYGMLPALLGWLYGFFWSLCQPSESP 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000  109 RAMRMVH-TCWLYYFSKFIELLDTIFFVLRKKnsQVTFLHVFHHTIMPWTWWFGVKFAAGGLGTFHAFLNTAVHVVMYSY 187
Cdd:pfam01151  80 FAQGLVGfWYYLFYLSKILELLDTVFLVLRKK--QLSFLHVYHHSTMLLYSWLGYKYGTGGVGWFFILLNSFVHVIMYFY 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 148540000  188 YGLCAMGpayQKYL--WWKKHLTSLQLVQFVLVTIHIGQIFFM-----EDCNYQyPVFLYIIMSYGCIFLLLFLHFWYRA 260
Cdd:pfam01151 158 YFLAALG---NKKLprWWKKYITQLQILQFVIGLAHTVYALYQyylgpYGCDGP-RFAARLGLVMYLSYLFLFSNFYIKS 233

                  ....*....
gi 148540000  261 YTKGQRLPK 269
Cdd:pfam01151 234 YLKPKKKKA 242
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH